Results 231 to 240 of about 2,208,548 (262)

Dimethyl Fumarate, But Not Rituximab, Reduces Serum GFAP Levels and PIRMA in Relapsing–Remitting MS

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) levels are believed to reflect mainly acute and chronic disease processes in multiple sclerosis (MS), respectively. In this study, we investigated whether dimethyl fumarate (DMF) and rituximab (RTX) differentially affect these biomarkers.
F. Shawket, J. Lycke, J. Salzer, F. Piehl, K. Fink, N. Lange, J. Mellergård, C. Malmeström, P. Sundström, I. Erngren, A. al‐Grety, E. Freyhult, K. Kultima, J. Burman, A. Svenningsson   +14 more
wiley   +1 more source

Effect of electronic drug-drug interaction alerts on patient and clinician outcomes: a systematic review. [PDF]

J Am Med Inform Assoc
Holbrook AM, Silva JM, Faruque JAY, Deng J, Schneider T, Jaffer A.   +5 more
europepmc   +1 more source

Persistent Bilateral [18F]THK5351 and Migrating Unilateral [18F]FDG Uptake in Anti‐LGI1 Encephalitis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Anti–leucine‐rich glioma‐inactivated 1 encephalitis (LGI1‐E) can cause persistent cognitive deficits, but the mechanisms remain unclear. A 40‐year‐old woman with LGI1‐E presented with subacute cognitive deficits and showed mild left medial temporal lobe (MTL) swelling and fluid‐attenuated inversion recovery (FLAIR) hyperintensity on initial ...
Yusuke Akitomi, Kenichiro Taira, Masanori Kurihara, Kenji Ishibashi, Kenji Ishii, Fumio Suzuki, Aya Midori Tokumaru, Makoto Hara, Atsushi Iwata   +8 more
wiley   +1 more source

A comparison of five different drug-drug interaction checkers for selective serotonin reuptake inhibitors. [PDF]

Front Pharmacol
Xu S, Song Z, Li Y, Bai J, Wang D, Wang E, Wang J.   +6 more
europepmc   +1 more source

Sertraline Treatment Can Mimic Niemann‐Pick Type C Biomarker Profile: A Diagnostic Pitfall

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Oxysterols (cholestane‐3β,5α,6β‐triol and 7‐ketocholesterol) and N‐palmitoyl‐O‐phosphocholineserine (PPCS) are sensitive biomarkers for Niemann‐Pick disease type C (NPC) screening. However, false‐positive results occur, with a biomarker profile suggestive of NPC despite the absence of pathogenic variants in genes involved in NPC or ...
Maria Makrygianni, Cecile Pagan, Antony Citterio‐Quentin, Isabelle Rouvet, Giulia Dingeo, Cyril Hanin, Claudine Laurent‐Levinson, Samia Pichard, Bénédicte Héron, Clément Gourguechon, Daniele Mandia, Jerome Guitton, Carole Lacout, Nicolas Schleinitz, Florient Potier, Olivier Flabeau, Elsa Besse‐Pinot, Foudil Lamari, Magali Pettazzoni, Yann Nadjar   +19 more
wiley   +1 more source

Drug-Drug Interaction Knowledge, Practices, and Barriers in Community Pharmacies: A Cross-Sectional Study from Jazan Region, Saudi Arabia. [PDF]

Pharmacy (Basel)
Alfarhan M, Haqwi MF, Musayyikh AH, Ashqar J, Suwidi LY, Fageh AH, Alajam EA, Almansour H, Alshammari TM, Al-Qahtani S.   +9 more
europepmc   +1 more source

InterPAD is a database of drug-drug interaction between phytochemicals and anticancer drugs. [PDF]

Sci Rep
Zhang A, Sun X, Wu Q, Jiang H, Xu L, Gao Q, Yang Z, Zhu S, Sui X.   +8 more
europepmc   +1 more source

Data mining results for reduction of adverse drug-drug interaction events in older adults are clinically applicable. [PDF]

Ther Adv Drug Saf
Hunold KM, Shi Y, Zhang P, Donneyong MM, Ulintz A, Buck BH, Gordon JI, Pusateri A, Rayan M, Brownlowe K, Caterino JM.   +10 more
europepmc   +1 more source

Correction to: A real-world pharmacovigilance study of adverse events associated with esketamine: disproportionality analysis and detection of potential drug-drug interaction signals. [PDF]

Eur J Clin Pharmacol
Pisanu C, Imai S, Tsuchiya M, Inoue M, Ikegami K, Zammarchi G, Kizaki H, Hori S.   +7 more
europepmc   +1 more source

Assessment of Telisotuzumab Vedotin Drug-Drug Interaction Potential Using Physiologically-Based Pharmacokinetic Modeling and Simulations. [PDF]

J Clin Pharmacol
Riad MMH, Brunsdon P, Menon R, Marroum P, Parikh A.   +4 more
europepmc   +1 more source